These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1124 related items for PubMed ID: 16494995
1. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families. Achatz MI, Olivier M, Le Calvez F, Martel-Planche G, Lopes A, Rossi BM, Ashton-Prolla P, Giugliani R, Palmero EI, Vargas FR, Da Rocha JC, Vettore AL, Hainaut P. Cancer Lett; 2007 Jan 08; 245(1-2):96-102. PubMed ID: 16494995 [Abstract] [Full Text] [Related]
2. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil. Giacomazzi J, Selistre SG, Rossi C, Alemar B, Santos-Silva P, Pereira FS, Netto CB, Cossio SL, Roth DE, Brunetto AL, Zagonel-Oliveira M, Martel-Planche G, Goldim JR, Hainaut P, Camey SA, Ashton-Prolla P. Cancer; 2013 Dec 15; 119(24):4341-9. PubMed ID: 24122735 [Abstract] [Full Text] [Related]
3. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes. Ruijs MW, Verhoef S, Rookus MA, Pruntel R, van der Hout AH, Hogervorst FB, Kluijt I, Sijmons RH, Aalfs CM, Wagner A, Ausems MG, Hoogerbrugge N, van Asperen CJ, Gomez Garcia EB, Meijers-Heijboer H, Ten Kate LP, Menko FH, van 't Veer LJ. J Med Genet; 2010 Jun 15; 47(6):421-8. PubMed ID: 20522432 [Abstract] [Full Text] [Related]
4. Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil. Palmero EI, Schüler-Faccini L, Caleffi M, Achatz MI, Olivier M, Martel-Planche G, Marcel V, Aguiar E, Giacomazzi J, Ewald IP, Giugliani R, Hainaut P, Ashton-Prolla P. Cancer Lett; 2008 Mar 08; 261(1):21-5. PubMed ID: 18248785 [Abstract] [Full Text] [Related]
5. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Olivier M, Goldgar DE, Sodha N, Ohgaki H, Kleihues P, Hainaut P, Eeles RA. Cancer Res; 2003 Oct 15; 63(20):6643-50. PubMed ID: 14583457 [Abstract] [Full Text] [Related]
6. Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome. Birch JM, Blair V, Kelsey AM, Evans DG, Harris M, Tricker KJ, Varley JM. Oncogene; 1998 Sep 03; 17(9):1061-8. PubMed ID: 9764816 [Abstract] [Full Text] [Related]
8. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Varley JM, McGown G, Thorncroft M, Santibanez-Koref MF, Kelsey AM, Tricker KJ, Evans DG, Birch JM. Cancer Res; 1997 Aug 01; 57(15):3245-52. PubMed ID: 9242456 [Abstract] [Full Text] [Related]
9. [Germline mutations of the p53 gene]. Frebourg T. Pathol Biol (Paris); 1997 Dec 01; 45(10):845-51. PubMed ID: 9769948 [Abstract] [Full Text] [Related]
10. Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Birch JM, Alston RD, McNally RJ, Evans DG, Kelsey AM, Harris M, Eden OB, Varley JM. Oncogene; 2001 Aug 02; 20(34):4621-8. PubMed ID: 11498785 [Abstract] [Full Text] [Related]
11. The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations. Finkova A, Vazna A, Hrachovina O, Bendova S, Prochazkova K, Sedlacek Z. Cancer Genet Cytogenet; 2009 Aug 02; 193(1):63-6. PubMed ID: 19602465 [Abstract] [Full Text] [Related]
12. High frequency of de novo mutations in Li-Fraumeni syndrome. Gonzalez KD, Buzin CH, Noltner KA, Gu D, Li W, Malkin D, Sommer SS. J Med Genet; 2009 Oct 02; 46(10):689-93. PubMed ID: 19556618 [Abstract] [Full Text] [Related]
14. Germ line BAX alterations are infrequent in Li-Fraumeni syndrome. Barlow JW, Mous M, Wiley JC, Varley JM, Lozano G, Strong LC, Malkin D. Cancer Epidemiol Biomarkers Prev; 2004 Aug 02; 13(8):1403-6. PubMed ID: 15298965 [Abstract] [Full Text] [Related]
15. Li-Fraumeni and Li-Fraumeni-like syndrome mutations in p53 are associated with exonic methylation and splicing regulatory elements. Kouidou S, Malousi A, Maglaveras N. Mol Carcinog; 2009 Oct 02; 48(10):895-902. PubMed ID: 19367569 [Abstract] [Full Text] [Related]
16. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes. Andrade RC, Dos Santos AC, de Aguirre Neto JC, Nevado J, Lapunzina P, Vargas FR. Fam Cancer; 2017 Apr 02; 16(2):243-248. PubMed ID: 27714481 [Abstract] [Full Text] [Related]
17. Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect. Garritano S, Gemignani F, Palmero EI, Olivier M, Martel-Planche G, Le Calvez-Kelm F, Brugiéres L, Vargas FR, Brentani RR, Ashton-Prolla P, Landi S, Tavtigian SV, Hainaut P, Achatz MI. Hum Mutat; 2010 Feb 02; 31(2):143-50. PubMed ID: 19877175 [Abstract] [Full Text] [Related]
18. Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome. Palmero EI, Achatz MI, Ashton-Prolla P, Olivier M, Hainaut P. Curr Opin Oncol; 2010 Jan 02; 22(1):64-9. PubMed ID: 19952748 [Abstract] [Full Text] [Related]